CRL vs OSPN · rev $2.00B vs P/E 7.6, rev $60.5M
Charles River Laboratories (CRL) versus OneSpan Inc (OSPN) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
OneSpan Inc (OSPN) is a software - infrastructure company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported OSPN revenue for 2026-06-30 was $60.5M. Net income was $6.8M. Revenue was down 8.3% from 2026-03-31 to 2026-06-30. OSPN currently screens at market cap $509.0M and trailing P/E 7.6.
CRL currently screens at market cap $7.78B. OSPN currently screens at market cap $509.0M and trailing P/E 7.6.
Not investment advice. Open the CRL and OSPN stock pages for the full models.
Not investment advice.